Form 4: Eli Lilly Director Acquires Shares Through Deferral Plan

Eli Lilly director Kimberly H. Johnson acquired 17 shares of common stock through a deferral plan, as reported in a recent SEC filing.

Summary

• Kimberly H. Johnson, a director at Eli Lilly & Co, acquired 17 shares of common stock on December 18, 2023.
• The shares were acquired at a price of $579.76 per share.
• This acquisition was made through the Lilly Directors' Deferral Plan, where the shares are deferred in lieu of cash compensation.
• The shares will be settled in common stock after Ms. Johnson's separation from service.
• Following this transaction, Ms. Johnson directly owns 2,569 shares of Eli Lilly common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction, which is generally positive as it indicates director confidence, but it is not a major event.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Future Outlook

The acquired shares will be settled in common stock following the reporting person's separation from service.

Industry Context

Director share acquisitions are a common occurrence in publicly traded companies and are often seen as a sign of confidence in the company's future prospects.

Comparison to Industry Standards

• Director share acquisitions are a standard practice across publicly listed companies.
• The use of deferral plans for director compensation is also a common practice.
• The specific number of shares acquired is relatively small, which is typical for individual director transactions.

Stakeholder Impact

• The share acquisition by a director may have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Eli Lilly, Director, Share Acquisition, Deferral Plan, SEC Form 4, Kimberly H. Johnson, Stock Units